Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros


Bases de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Genome Biol ; 2(10): RESEARCH0044, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11597336

RESUMO

BACKGROUND: The genome of Mycobacterium tuberculosis H37Rv has five copies of a cluster of genes known as the ESAT-6 loci. These clusters contain members of the CFP-10 (lhp) and ESAT-6 (esat-6) gene families (encoding secreted T-cell antigens that lack detectable secretion signals) as well as genes encoding secreted, cell-wall-associated subtilisin-like serine proteases, putative ABC transporters, ATP-binding proteins and other membrane-associated proteins. These membrane-associated and energy-providing proteins may function to secrete members of the ESAT-6 and CFP-10 protein families, and the proteases may be involved in processing the secreted peptide. RESULTS: Finished and unfinished genome sequencing data of 98 publicly available microbial genomes has been analyzed for the presence of orthologs of the ESAT-6 loci. The multiple duplicates of the ESAT-6 gene cluster found in the genome of M. tuberculosis H37Rv are also conserved in the genomes of other mycobacteria, for example M. tuberculosis CDC1551, M. tuberculosis 210, M. bovis, M. leprae, M. avium, and the avirulent strain M. smegmatis. Phylogenetic analyses of the resulting sequences have established the duplication order of the gene clusters and demonstrated that the gene cluster known as region 4 (Rv3444c-3450c) is ancestral. Region 4 is also the only region for which an ortholog could be found in the genomes of Corynebacterium diphtheriae and Streptomyces coelicolor. CONCLUSIONS: Comparative genomic analysis revealed that the presence of the ESAT-6 gene cluster is a feature of some high-G+C Gram-positive bacteria. Multiple duplications of this cluster have occurred and are maintained only within the genomes of members of the genus Mycobacterium.


Assuntos
Antígenos de Bactérias/genética , Família Multigênica , Mycobacterium tuberculosis/genética , Mycobacterium/genética , Proteínas de Bactérias , Corynebacterium diphtheriae/genética , DNA Bacteriano/genética , Sequência Rica em GC , Genoma Bacteriano , Bactérias Gram-Positivas/genética , Mycobacterium avium/genética , Mycobacterium avium subsp. paratuberculosis/genética , Mycobacterium bovis/genética , Mycobacterium leprae/genética , Mycobacterium smegmatis/genética , Filogenia , Análise de Sequência de DNA , Streptomyces/genética
2.
Biochem Pharmacol ; 37(24): 4635-41, 1988 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-2849452

RESUMO

The anti-leprosy agent, clofazimine, at concentrations of 0.1-5 micrograms/ml caused a dose-related, stimulus-non-specific (N-formyl-methionyl-leucyl-phenylalanine, calcium ionophore, opsonised zymosan, arachidonic acid and phorbol myristate acetate) potentiation of superoxide generation by human neutrophils in vitro without affecting basal oxidative responses. The pro-oxidative interactions of clofazimine with neutrophils were eliminated by the phospholipase A2 inhibitor 4-p-bromophenacyl bromide but not by the protein kinase C (PKC) inhibitor H-7. In support of these observations clofazimine promoted the release of radiolabeled arachidonic acid from neutrophil membrane phospholipids but did not influence the activity of PKC in cytosolic extracts of neutrophils or of purified PKC from rat brain. Pro-oxidative interactions of clofazimine with human phagocytes may contribute to the intraphagocytic antimycobacterial activity of this agent.


Assuntos
Clofazimina/farmacologia , Neutrófilos/metabolismo , Fosfolipases A/metabolismo , Fosfolipases/metabolismo , 1-(5-Isoquinolinasulfonil)-2-Metilpiperazina , Acetofenonas/farmacologia , Ácido Araquidônico , Ácidos Araquidônicos/metabolismo , Relação Dose-Resposta a Droga , Humanos , Técnicas In Vitro , Isoquinolinas/farmacologia , N-Formilmetionina Leucil-Fenilalanina/farmacologia , Neutrófilos/efeitos dos fármacos , Fosfolipases A2 , Piperazinas/farmacologia , Proteína Quinase C/metabolismo , Superóxidos/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA